BiotechTube

Tetanus & Diphtheria booster vaccine (Td) + TwinrixTM [Hepatitis A Inactivated & Hepatitis B (Recombinant) Vaccine] + Dukoral® Traveler's Diarrhea Vaccine (WC/rBS)

Pre-clinicalCompleted
1 views this week 0 watching💤 Quiet
Interest: 26/100
26
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Vaccine Response Impaired

Conditions

Vaccine Response Impaired

Trial Timeline

Jul 1, 2010 → Nov 1, 2011

NCT ID
NCT01119703

About Tetanus & Diphtheria booster vaccine (Td) + TwinrixTM [Hepatitis A Inactivated & Hepatitis B (Recombinant) Vaccine] + Dukoral® Traveler's Diarrhea Vaccine (WC/rBS)

Tetanus & Diphtheria booster vaccine (Td) + TwinrixTM [Hepatitis A Inactivated & Hepatitis B (Recombinant) Vaccine] + Dukoral® Traveler's Diarrhea Vaccine (WC/rBS) is a pre-clinical stage product being developed by Merck for Vaccine Response Impaired. The current trial status is completed. This product is registered under clinical trial identifier NCT01119703. Target conditions include Vaccine Response Impaired.

What happened to similar drugs?

8 of 20 similar drugs in Vaccine Response Impaired were approved

Approved (8) Terminated (0) Active (12)
✅Vaxelis™MerckApproved
✅21-valent pneumococcal conjugate vaccineMerckApproved
✅Pneumococcal VaccineMerckApproved
🔄9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses + 9-valent human papillomavirus vaccine (Gardasil 9) - 2 doses + 9-valent human papillomavirus vaccine (Gardasil 9) - 1 doseMerckPhase 3
✅Gardasil-9MerckApproved
🔄Rotarix + RotaTeqMerckPhase 3
✅Human papillomavirus 9-valent vaccine, recombinant + human papillomavirus vaccine, recombinantMerckApproved

Hype Score Breakdown

Clinical
3
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01119703Pre-clinicalCompleted

Competing Products

20 competing products in Vaccine Response Impaired

See all competitors
ProductCompanyStageHype Score
AZD1222AstraZenecaPre-clinical
26
Vaxelis™MerckApproved
43
21-valent pneumococcal conjugate vaccineMerckApproved
50
Pneumococcal VaccineMerckApproved
50
Quadrivalent HPV [Type 6, 11, 16 and 18] L1 Virus-Like Particle VaccineMerckPre-clinical
26
quadrivalent human papillomavirus vaccine + quadrivalent human papillomavirus vaccineMerckPre-clinical
26
9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses + 9-valent human papillomavirus vaccine (Gardasil 9) - 2 doses + 9-valent human papillomavirus vaccine (Gardasil 9) - 1 doseMerckPhase 3
36
Gardasil-9MerckApproved
39
Rotarix + RotaTeqMerckPhase 3
40
Human papillomavirus 9-valent vaccine, recombinant + human papillomavirus vaccine, recombinantMerckApproved
50
Seasonal Influenza VaccineNovartisPhase 3
40
Fluad + SalineNovartisApproved
43
Monovalent inactivated influenza vaccineNovartisPhase 2
35
cTIVNovartisPhase 3
40
Monovalent inactivated influenza vaccineNovartisPhase 3
40
Fluad H5N1 Pandemic Influenza VaccineNovartisPhase 2
35
13-valent pneumococcal conjugate vaccine + 7-valent pneumococcal conjugate vaccinePfizerPhase 3
40
13-valent pneumococcal conjugate vaccine + 13-valent pneumococcal conjugate vaccinePfizerPhase 3
40
13vPnC + 23vPSPfizerPhase 3
40
13-valent pneumococcal conjugate vaccine + 13-valent pneumococcal conjugate vaccinePfizerApproved
43